Market Pulse Pfizer reports positive results in trial of vaccine for immunocompromised adults at risk of severe RSV-related illness August 12, 2024 Share Facebook Twitter Pinterest LinkedIn Read Time:0 Second Post Content About Post Author Happy 0 0 % Sad 0 0 % Excited 0 0 % Sleepy 0 0 % Angry 0 0 % Surprise 0 0 %
Sage Therapeutics’ stock slides after Alzheimer’s Disease trial fails to meet main goal Post Content October 8, 2024
Scholar Rock’s stock soars more than 200% on positive trial of treatment for spinal muscular atrophy Post Content October 7, 2024
Chevron Canada to sell assets to Canadian Natural Resources for $6.5 billion in cash Post Content October 7, 2024
Barnes’ stock jumps 2.7% after company agrees to be acquired by Apollo for $3.6 billion in cash Post Content October 7, 2024
Silver miner SilverCrest’s stock surges after Coeur Mining’s $1.7 billion buyout bid Post Content October 4, 2024